AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3269
+0.0369 (12.72%)
Sep 11, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $16.31 million as of September 11, 2026. Its market cap has increased by 89.51% in one year.
Market Cap
16.31M
Enterprise Value
15.65M
1-Year Change
89.51%
Ranking
Category
Stock Price
$0.33
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $16.31M, a decrease of -74.38%. That is a compound annual growth rate of -22.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 16.31M | 25.22% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 17.71M |
| Cerenome | 17.65M |
| Dyadic International | 17.64M |
| Niki BioSolutions | 16.78M |
| Enlivex | 16.78M |
| PDS Biotechnology | 16.51M |
| BioCardia | 16.35M |
| Passage Bio | 16.09M |